| Mus musculus |
ERX536812 |
ERP006644 |
10090 |
NA |
INSDC status: public |
NEB |
NA |
NA |
| NA |
SRX25489922 |
SRP521901 |
5207 |
NA |
NA |
Qiagen_UMI |
NA |
NA |
| Homo sapiens |
SRX8053447 |
SRP255171 |
9606 |
isolated CD19+ CLL cells |
tissue: isolated CD19+ CLL cells |
Illumina |
NA |
NA |
| Mus musculus |
ERX536811 |
ERP006644 |
10090 |
NA |
INSDC status: public |
NEB |
NA |
NA |
| NA |
SRX12876521 |
SRP344006 |
4787 |
Mycelium |
treatment: 0 ug/ml of mefenoxam |
NEB |
NA |
NA |
| NA |
SRX25489929 |
SRP521901 |
5207 |
NA |
NA |
Qiagen_UMI |
NA |
NA |
| Rattus norvegicus |
SRX4963307 |
SRP167384 |
10116 |
liver |
duration of diabetic phenotype: 2 weeks |
Illumina |
NA |
NA |
| Mus musculus |
ERX536810 |
ERP006644 |
10090 |
NA |
INSDC status: public |
NEB |
NA |
NA |
| NA |
SRX25489928 |
SRP521901 |
5207 |
NA |
NA |
Qiagen_UMI |
NA |
NA |
| NA |
SRX25489927 |
SRP521901 |
5207 |
NA |
NA |
Qiagen_UMI |
NA |
NA |
| NA |
SRX25489926 |
SRP521901 |
5207 |
NA |
NA |
Qiagen_UMI |
NA |
NA |
| NA |
SRX12876525 |
SRP344006 |
4787 |
Mycelium |
treatment: 100 ug/ml of mefenoxam |
NEB |
NA |
NA |
| Homo sapiens |
SRX21600049 |
SRP458080 |
9606 |
serum-derived extracellular vesicles |
tissue: serum-derived extracellular vesicles |
Qiagen_UMI |
NA |
NA |
| Homo sapiens |
SRX8053442 |
SRP255171 |
9606 |
isolated CD19+ CLL cells |
tissue: isolated CD19+ CLL cells |
Illumina |
NA |
NA |
| NA |
SRX12876524 |
SRP344006 |
4787 |
Mycelium |
treatment: 100 ug/ml of mefenoxam |
NEB |
NA |
NA |
| Homo sapiens |
SRX21600048 |
SRP458080 |
9606 |
serum-derived extracellular vesicles |
tissue: serum-derived extracellular vesicles |
Qiagen_UMI |
NA |
NA |
| Homo sapiens |
SRX8053441 |
SRP255171 |
9606 |
isolated CD19+ CLL cells |
tissue: isolated CD19+ CLL cells |
Illumina |
NA |
NA |
| NA |
SRX12876523 |
SRP344006 |
4787 |
Mycelium |
treatment: 0 ug/ml of mefenoxam |
other |
NA |
NA |
| Homo sapiens |
SRX21600047 |
SRP458080 |
9606 |
serum-derived extracellular vesicles |
tissue: serum-derived extracellular vesicles |
Qiagen_UMI |
NA |
NA |
| Homo sapiens |
SRX8053440 |
SRP255171 |
9606 |
isolated CD19+ CLL cells |
tissue: isolated CD19+ CLL cells |
Illumina |
NA |
NA |
| NA |
SRX12876522 |
SRP344006 |
4787 |
Mycelium |
treatment: 0 ug/ml of mefenoxam |
NEB |
NA |
NA |
| Homo sapiens |
SRX21600046 |
SRP458080 |
9606 |
serum-derived extracellular vesicles |
tissue: serum-derived extracellular vesicles |
Qiagen_UMI |
NA |
NA |
| NA |
SRX12876529 |
SRP344006 |
4787 |
Mycelium |
treatment: 0 ug/ml of mefenoxam |
NEB |
NA |
NA |
| Homo sapiens |
SRX21600045 |
SRP458080 |
9606 |
serum-derived extracellular vesicles |
tissue: serum-derived extracellular vesicles |
Qiagen_UMI |
NA |
NA |
| Homo sapiens |
SRX8053446 |
SRP255171 |
9606 |
isolated CD19+ CLL cells |
tissue: isolated CD19+ CLL cells |
Illumina |
NA |
NA |
